000047767 000__ 01146nam\a2200397\i\4500
000047767 001__ 47767
000047767 003__ SzGeWIPO
000047767 005__ 20230503163030.0
000047767 006__ m\\\\eo\\d\\\\\\\\
000047767 007__ cr bn |||m|||a
000047767 008__ 230320s2023\\\\enk\\\\\o\\\\\000\0\eng\d
000047767 035__ $$a(OCoLC)1373643244
000047767 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000047767 041__ $$aeng
000047767 24500 $$aBristol-Myers Squibb seeks further immuno-oncology patent revenues with AstraZeneca suit.
000047767 264_1 $$a[London, England] :$$bGlobe Business Media Group,$$c2023.
000047767 300__ $$a1 online resource
000047767 336__ $$atext$$2rdacontent
000047767 337__ $$acomputer$$2rdamedia
000047767 338__ $$aonline resource$$bcr$$2rdacarrier
000047767 4901_ $$aIntellectual Asset Management, IAM,$$x1741-1424 ;$$v2023
000047767 542__ $$fhttps://www.iam-media.com/article/bristol-myers-squibb-seeks-further-immuno-oncology-patent-revenues-astrazeneca-suit
000047767 588__ $$aCrossref
000047767 590__ $$aPublished online: 26-Jan-23
000047767 650_0 $$aIntellectual property.
000047767 650_4 $$aJapan.
000047767 650_4 $$aBiomedical Research.
000047767 650_4 $$aIntellectual Property Law$$zUnited States of America.
000047767 650_4 $$aPharmaceuticals.
000047767 7001_ $$aHouldsworth, Adam,$$eauthor.
000047767 7731_ $$tIntellectual Asset Management$$wIAM
000047767 830_0 $$aIntellectual Asset Management, IAM,$$x1741-1424 ;$$v2023.
000047767 85641 $$uhttps://www.iam-media.com/article/bristol-myers-squibb-seeks-further-immuno-oncology-patent-revenues-astrazeneca-suit$$yonline version
000047767 904__ $$aArticle
000047767 980__ $$aIAM